Northwire Canada EditionFriday, October 16, 2026
Northwire
⌕
GOLD 4197.50 +0.7% SILVER 57.55 +0.7% COPPER 6.60 +0.6% OIL 95.82 −2.2% PALLADIUM 1122.50 −0.5% MON 0.385 −6.1% OMI 0.250 +0.0% BUFF 0.800 +2.6% FEO 0.670 +3.1% LIB 0.720 +0.0% NPR 0.640 +3.2% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.355 +4.4% PHNM 0.345 +1.5% SLG 5.60 −1.9% CASA 0.065 +8.3% DRY 0.225 +4.7% SOMA 0.570 +1.8% GOLD 4197.50 +0.7% SILVER 57.55 +0.7% COPPER 6.60 +0.6% OIL 95.82 −2.2% PALLADIUM 1122.50 −0.5% MON 0.385 −6.1% OMI 0.250 +0.0% BUFF 0.800 +2.6% FEO 0.670 +3.1% LIB 0.720 +0.0% NPR 0.640 +3.2% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.355 +4.4% PHNM 0.345 +1.5% SLG 5.60 −1.9% CASA 0.065 +8.3% DRY 0.225 +4.7% SOMA 0.570 +1.8%
Earnings

Organto Foods Announces Third Quarter 2025 Financial Results

OGO · Price

Executive Summary

  • Organto Foods reported record third‑quarter sales of $15.1 M (↑189% YoY) and nine‑month sales of $45.9 M (↑222% YoY).
  • Despite strong revenue growth, the company posted a net loss of $2.0 M for Q3 and $9.6 M for the nine‑month period, driven by derivative losses and debt‑settlement costs.
  • The balance sheet was materially strengthened: cash rose to $8.8 M (from $0.3 M) and working capital improved to $8.6 M (from –$14.6 M).

Key Details

  • Quarterly Sales: $15.1 M, up 189% YoY; largest Q3 sales in company history.
  • Quarterly Gross Profit: $1.2 M (↑101% YoY); gross profit margin 8.2% of sales.
  • Quarterly EBITDA: $(0.7) M (loss), impacted by currency‑hedge derivative losses.
  • Nine‑Month Sales: $45.9 M, up 222% YoY; already 122% greater than FY2024 total ($20.7 M).
  • Nine‑Month Gross Profit: $3.6 M (↑208% YoY); gross profit margin 7.7% of sales.
  • Nine‑Month EBITDA: $(0.9) M (loss), also affected by derivative losses.
  • Net Loss Q3: $2.0 M (includes $0.4 M interest/acc. costs, $0.4 M derivative loss, $0.1 M debt restructuring cost, $1.7 M debt settlement loss).
  • Net Loss Nine‑Month: $9.6 M (includes $0.6 M interest/acc. costs, $2.3 M derivative loss, $0.8 M debt restructuring cost, $5.5 M debt settlement loss).
  • Cash Position: $8.8 M (excluding restricted cash) vs. $0.3 M at 12‑31‑2024.
  • Working Capital: $8.6 M vs. –$14.6 M at 12‑31‑2024.
  • Debt Reduction: Short‑term loans & convertible debentures down to $2.5 M from $12.5 M (12‑31‑2024).
  • Warrant Exercise: June 2025 private placement issued 4,000,000 units @ $0.25/unit ($1.0 M gross). Holders exercised half‑share warrants for 1,000,000 common shares at $0.35/share, generating $350,000 cash; shares released from hold period on 27‑Oct‑2025.

Notable Quotes

  • “These results are the outcome of the extensive restructuring and business realignment we've executed over the past 21 months… we believe sets a solid foundation for sustained growth, stability, and a clear path to profitability.” – Steve Bromley, Co‑Chair & CEO

Materiality Assessment: Material – Neutral (significant financial performance and balance‑sheet changes disclosed).

Read the original news release →

More from Organto Foods Inc.